Advantage X

Advantage Capital is a venture capital firm founded in 1992, headquartered in New Orleans, Louisiana, with additional offices across the United States. The firm specializes in growth equity, lending, and mezzanine debt investments, focusing primarily on small businesses at various stages of development, excluding seed stage. Advantage Capital targets investments in low-income communities, both urban and rural, and supports economic development initiatives. The firm seeks to invest in companies that utilize proprietary technologies in sectors such as communication, information technology, pharmaceuticals, biotechnology, and energy, among others. It offers various forms of debt capital, including senior and mezzanine debt, and has a preference for co-investing with other firms. Initial investments typically range from $0.5 million to $10 million in companies with sales under $5 million, with potential for larger investments based on milestones. Advantage Capital is committed to addressing the funding gaps in underserved areas and fostering economic growth in communities that lack traditional sources of risk capital.

Al Alvarez

Director

Brian Anderson

PRINCIPAL

Alyson G. Appleton

VP of Communications, Marketing and Policy

Daniel Barrett

Associate

Jay Bennett

Vice President of Business Development

Keith Berry

VP of Business Development

Anthony H. Billings

Vice President

Bitting, Thomas H.P.

PRINCIPAL

Troy Blaine

VP of Business Development

Charles H. Booker

Principal

Ryan Brennan

Managing Director

Samantha F. de Castro

Associate

Abhi Chandrasekhara

Senior Associate

Craig Cole

Vice President of Business Development

Chloe Coniaris

SENIOR ASSOCIATE

Adam Constantinides

SENIOR ASSOCIATE

Jeffrey W. Craver

Principal

Anaëlle Croteau

ASSOCIATE

Jeremy R. Degenhart

Principal

Maurice Doyle

Managing Director

Ryan Dressler

Principal

Louis T. Dubuque

Managing Director

Eric Dunham

VP of Business Development

Michele Fleher

Business development officer

Beth Fore

SENIOR ASSOCIATE

Keith Freeman

Managing Director

Jeffrey Gentsch

Venture Partner

Gregory P. Gish

Senior Vice President

Jonathan I. Goldstein

Managing Director

Daniel J. Gould

SVP

Matthew L. Hart

VP

Joseph Henderson

SENIOR ASSOCIATE

Leah Hendricks

Vice-President

George N. Hettich

VP

Stephanie Hiatt

SVP

Richard T. Hummell

Principal

Reid Hutchins

Managing Director

Geoffrey Jacques

ASSOCIATE

Mark Lange

VP of Business Development

Josh Liggett

Partner

Franchesca B. Lorio

Principal/Controller

Philip E. Marshall

Principal

Larry Martin

VP of Business Development

Natalia Matallana

Senior Associate

D. Tyler Mayoras

Venture Partner

Anthony Metzner

SVP

Arjun Mohan

ASSOCIATE

Sandra M. Moore

Managing Director/Chief Impact Officer

Justin T. Motika

VP

Scott Murphy

Managing Director & Chief Investment Officer

James O'Rourke

MD

Justin N. Obletz

Chief Financial Officer

Paul Olsen

VP

Anne Ott

SVP

Tim Perusek

Principal

Aaron Pohlmann

Senior Associate

Sarah Rajan

Senior Associate

Jim Rieker

VP OF SYNDICATION

Rachel Robards

ASSOCIATE

Josh Rogers

SVP

Joshua Rogers

Vice-President

Gabe Rosen

SENIOR ASSOCIATE

Valentino Rovere

Vice President

Philip Ruppel

Vice President

Kelcee Sachtleben

Senior Associate

Brynn N. Sanders

VP

Cara M. Schiffman

Vice-President of Regulatory Affairs

Greg Schwarztrauber

SVP

Talmadge Singer

Managing Director

Craig Smidt

SVP

Ruth Kelso Sorrell

Principal

Angel Stuckman

VP of Business Development

Adam M. Suberi

Director of Financial Planning and Analysis

Matthew Switzer

SENIOR ASSOCIATE

Thomas Titus

Vice President

W. Anthony Toups

Principal

Alexandra A. Twyman

SENIOR ASSOCIATE

Ramya Varma

Vice President

Brittany Walker

Assistant VP

Benjamin Warning

Senior Associate

Carl Weatherley-White

MD

Thomas Willsey

Senior Vice President, Treasurer

Kyle Wood

Associate

Sarah Wynn

Associate

Mui, Fong Wa C.

VP

J.P. Lynch

Senior Analyst

Past deals in New Jersey

Momentum Solar

Debt Financing in 2018
Momentum Solar is a rapidly growing solar energy company that provides customized solar array installations for residential and commercial properties. The company focuses on generating clean and cost-effective power, allowing customers to save on their monthly electricity bills without any upfront expenses. Momentum Solar offers comprehensive services that include engineering, permitting, installation, and activation of solar systems, ensuring that each installation is tailored to meet the specific needs of the customer. Through these efforts, the company helps clients transition to renewable energy, contributing to a more sustainable future.

Momentum Solar

Venture Round in 2018
Momentum Solar is a rapidly growing solar energy company that provides customized solar array installations for residential and commercial properties. The company focuses on generating clean and cost-effective power, allowing customers to save on their monthly electricity bills without any upfront expenses. Momentum Solar offers comprehensive services that include engineering, permitting, installation, and activation of solar systems, ensuring that each installation is tailored to meet the specific needs of the customer. Through these efforts, the company helps clients transition to renewable energy, contributing to a more sustainable future.

Advanced Enviro Systems

Debt Financing in 2017
Advanced Enviro Systems LLC offers waste management and recycling solutions. The company was founded in 1996 and is based in Camden, New Jersey.

Advanced Enviro Systems

Series A in 2017
Advanced Enviro Systems LLC offers waste management and recycling solutions. The company was founded in 1996 and is based in Camden, New Jersey.

IPAK

Debt Financing in 2017
IPAK manufactures, warehouses, kits, and distributes sales, marketing, safety, and educational tools that support key business objectives.

IPAK

Series A in 2017
IPAK manufactures, warehouses, kits, and distributes sales, marketing, safety, and educational tools that support key business objectives.

2-20 Records Management

Venture Round in 2016
2-20 Records Management, LLC is an information management company that provides records storage and management services. The company’s services include document storage, document destruction, secure shredding, data protection, vault storage, imaging, and digital solutions. It serves accounting firms, architectural firms, financial services industries, government and healthcare customers, law firms, pharmaceutical companies, small businesses, mid-size businesses, and enterprise-size companies. The company is based in Edison, New Jersey. It also has operations in Arizona, Florida, Southern California, New York, and Pennsylvania.

2-20 Records Management

Debt Financing in 2016
2-20 Records Management, LLC is an information management company that provides records storage and management services. The company’s services include document storage, document destruction, secure shredding, data protection, vault storage, imaging, and digital solutions. It serves accounting firms, architectural firms, financial services industries, government and healthcare customers, law firms, pharmaceutical companies, small businesses, mid-size businesses, and enterprise-size companies. The company is based in Edison, New Jersey. It also has operations in Arizona, Florida, Southern California, New York, and Pennsylvania.

Cellectar Biosciences

Venture Round in 2008
Cellectar Biosciences is a clinical-stage biopharmaceutical company that specializes in the discovery, development, and commercialization of cancer therapies. The company’s lead candidate, CLR 131, is currently undergoing Phase II clinical trials for patients with relapsed or refractory multiple myeloma and various B-cell malignancies, alongside a Phase I study for the same indications. Cellectar is also advancing CLR 1900, a phospholipid drug conjugate chemotherapeutic program aimed at solid tumors. In addition, the company collaborates with several partners, including Pierre Fabre and Avicenna Oncology, to develop various PDC programs. Originally founded in 2002 and known as Novelos Therapeutics until its rebranding in 2014, Cellectar Biosciences has its headquarters in Florham Park, New Jersey, and is recognized for its innovative approach to combining lipid-like molecules and phospholipid ethers with radioisotopes for cancer treatment and imaging.